ten23 health has announced the launch of its quality control (QC) and testing services at its Basel (BASE) and Visp (VIVA2) facilities, following the receipt of GMP establishment licences from Swissmedic. The services were officially inaugurated with an event attended by
Hanns-Christian Mahler, Chief Enablement Officer at ten23 health, is redefining leadership in pharmaceutical manufacturing: “I believe collaboration at the workplace should be primarily based on trust and motivation, not on typical carrot and stick command and control models.” Founded in
ten23 health, a strategic CDMO is collaborating with BD (Becton, Dickinson and Company), a global medical technology company, to enhance aseptic manufacturing through the use of RFID-enabled prefillable syringes. The collaboration seeks to pilot the innovative BD iDFill™ solution, which
ten23 health® celebrated the grand opening of its VIVA2® facility in Visp, Switzerland, marking a key development in its contract development and manufacturing organisation (CDMO) services. The new site enhances ten23’s capacity for the sterile filling of vials, syringes, and
“My ambition for being a CDMO is that there will always be technical challenges, but I want to be transparent about the challenge and provide options to a customer.” Hanns-Christian Mahler, CEO of ten23 health, brings 15 years of sponsor-side
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
